慢性病中高血压管理的临床决策支持:一项随机临床试验
Lipika Samal1,2, John L Kilgallon1,3, Stuart Lipsitz1,2,4
1Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
JAMA internal medicine
|March 11, 2024
概括
一个计算机化的临床决策支持 (CDS) 系统通过增加对治疗建议的遵守,改善了慢性病 (CKD) 患者的高血压管理. 该系统显示,在CKD管理中,有可能获得更好的人口水平结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 医疗信息学 医疗信息学
背景情况:
- 高血压是美国3700万患有慢性病 (CKD) 的成年人不良后果的主要危险因素.
- 有效管理失控的高血压对于预防功能衰竭,心血管事件和慢性病患者的死亡率至关重要.
研究的目的:
- 评估一个计算机化临床决策支持 (CDS) 系统,旨在管理慢性病患者的失控高血压.
- 评估系统对缩血压 (SBP) 和治疗坚持的影响.
主要方法:
- 一个多临床随机试验,涉及174名初级保健医生 (PCP) 和2026名患有CKD和高血压的患者.
- 干预组接受了定制推的CDS;对照组接受了通常的护理.
- 主要结局:180天后平均SBP的变化;次要结局:BP控制和遵守建议.
主要成果:
- 与常规护理组相比,CDS干预组在统计学上显著地减少了平均SBP (-14.6 mm Hg vs -11.7 mm Hg).
- 两组之间实现血压控制的患者百分比没有显著差异.
- 干预组中显著更多的患者接受了与CDS建议一致的行动 (49.9%与34.6%相比).
结论:
- 计算机化的CDS系统有效地改善了慢性病患者不受控制的高血压的管理.
- 该系统增强了对基于证据的治疗建议的坚持,表明了改善人口水平临床结果的潜力.
相关概念视频
Heart Failure Drugs: Diuretics
375
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
375
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Dialysis
309
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
309
Antihypertensive Drugs: Direct Renin Inhibitors
625
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
625
Factors Affecting Renal Clearance: Renal Impairment
91
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429


